Trial Profile
Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 09 May 2019
Price :
$35
*
At a glance
- Drugs EVP-1001-1 (Primary)
- Indications Myocardial infarction
- Focus Diagnostic use
- 22 Dec 2015 New trial record